Delisting risk
RedHill Biopharma (ADR)
Specialty biopharmaceutical developer behind Talicia and a partner-led oral-medicine pipeline.
$0.7990
Pre-market−0.11 (−12.38%)
At close$0.9119(+37.96%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Nov '22Mar '23Jun '23Jun '23Feb '24Aug '24Oct '24Sep '25
Reported−$2.00$1.07$146.75$4.83−$0.20−$200.00$900.00−$1.15
Estimate−$0.30———−$0.03−$30.00——
Surprise−566.7%———−566.7%−566.7%——
RevenueReportedEstimate
Nov '22Mar '23Jun '23Jun '23Feb '24Aug '24Oct '24Sep '25
Reported$17.6M$12.8M$3.6M$1.8M———$2.0M
Estimate$21.5M$17.6M$3.6M$2.1M$17.6M$25.7M——
Surprise−18.4%−27.1%−0.6%−15.0%————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | −$435.00 | — | — |
| Apr 2026 | −$435.00 | — | — |
| Mar 2026 | −$435.00 | — | — |
| Sep 2025 | — | −$1.15 | — |
| Jun 2025 | — | — | — |
| Apr 2025 | — | — | — |
| Oct 2024 | — | $900.00 | — |
| Aug 2024 | −$30.00 | −$200.00 | −566.7% |
| Apr 2024 | — | — | — |
| Feb 2024 | −$0.03 | −$0.20 | −566.7% |
| Dec 2023 | — | — | — |
The latest year is open to everyone — the 35 quarters behind it read with an account. Sign in | |||
| Jun 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Jul 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Jul 2015 | |||
| Apr 2015 | |||
| Feb 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | −$435.00 | — | — | $22.7M | — | — | — |
| Apr 9, 2026 | −$435.00 | — | — | $22.7M | — | — | — |
| Mar 30, 2026 | −$435.00 | — | — | $22.7M | — | — | — |
| Sep 5, 2025 | — | −$1.15 | — | — | $2.0M | — | +0.7% |
| Jun 14, 2025 | — | — | — | — | — | — | — |
| Apr 10, 2025 | — | — | — | — | — | — | — |
| Oct 3, 2024 | — | $900.00 | — | — | — | — | +4.3% |
| Aug 29, 2024 | −$30.00 | −$200.00 | −566.7% | $25.7M | — | — | −1.4% |
| Apr 8, 2024 | — | — | — | — | — | — | — |
| Feb 12, 2024 | −$0.03 | −$0.20 | −566.7% | $17.6M | — | — | −2.6% |
| Dec 29, 2023 | — | — | — | $17.6M | — | — | — |
The latest year is open to everyone — the 35 quarters behind it read with an account. Sign in | |||||||
| Jun 30, 2023 | |||||||
| Jun 12, 2023 | |||||||
| Mar 27, 2023 | |||||||
| Nov 7, 2022 | |||||||
| Sep 23, 2022 | |||||||
| Jun 23, 2022 | |||||||
| Mar 17, 2022 | |||||||
| Nov 30, 2021 | |||||||
| Aug 26, 2021 | |||||||
| May 27, 2021 | |||||||
| Mar 18, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 13, 2020 | |||||||
| May 27, 2020 | |||||||
| Mar 4, 2020 | |||||||
| Nov 19, 2019 | |||||||
| Jul 23, 2019 | |||||||
| May 7, 2019 | |||||||
| Feb 26, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Aug 30, 2018 | |||||||
| May 8, 2018 | |||||||
| Feb 22, 2018 | |||||||
| Nov 13, 2017 | |||||||
| Jul 25, 2017 | |||||||
| May 3, 2017 | |||||||
| Feb 23, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Jul 26, 2016 | |||||||
| Apr 20, 2016 | |||||||
| Feb 25, 2016 | |||||||
| Nov 9, 2015 | |||||||
| Jul 29, 2015 | |||||||
| Apr 30, 2015 | |||||||
| Feb 26, 2015 | |||||||